ACTIVITY OF NEUROLIPID RECEPTORS CB1 AND S1P1 DURING ALZHEIMER’S DISEASE PROGRESSION

• Jonatan Martínez-Gardeazabal,
• Marta Moreno-Rodríguez,
• Manuel Fernández,
• Iván Fernández-Vega,
• Iván Manuel,
• Rafael Rodríguez-Puertas

Affiliations

Jonatan Martínez-Gardeazabal

University of the Basque Country (UPV/EHU), Department Of Pharmacology, Faculty Of Medicine And Nursing, Leioa, Spain

Marta Moreno-Rodríguez

University of the Basque Country (UPV/EHU), Department Of Pharmacology, Faculty Of Medicine And Nursing, Leioa, Spain

Manuel Fernández

Hospital Universitario Cruces, Department Of Neurology, Barakaldo, Spain; BioCruces Bizkaia Health Research Institute, Neurodegenerative Diseases, Barakaldo, Spain

Iván Fernández-Vega

University Hospital of Asturias (HUCA), Department Of Pathology, Oviedo, Spain; Health Research Institute of the Principality of Asturias (ISPA), Oviedo, Spain

Iván Manuel

University of the Basque Country (UPV/EHU), Department Of Pharmacology, Faculty Of Medicine And Nursing, Leioa, Spain; BioCruces Bizkaia Health Research Institute, Neurodegenerative Diseases, Barakaldo, Spain

Rafael Rodríguez-Puertas

University of the Basque Country (UPV/EHU), Department Of Pharmacology, Faculty Of Medicine And Nursing, Leioa, Spain; BioCruces Bizkaia Health Research Institute, Neurodegenerative Diseases, Barakaldo, Spain